Updates are available Correction dated 2025-09-19
Click to view Correction: https://doi.org/10.1038/s41375-025-02773-6
-
Authors
Ohlstrom, Denis
Bakhtiari, Mojtaba
Mumme, Hope
Michaud, Marina
De Janon Gutierrez, Alejandro https://orcid.org/0000-0003-1693-2913
DeRyckere, Deborah https://orcid.org/0000-0002-7457-9006
Ferguson, Katherine E.
Chien, Frank
Pilcher, William
Satpathy, Sarthak
Jordan, Sean https://orcid.org/0009-0003-2639-6269
Graham, Douglas https://orcid.org/0000-0002-6201-6900
Bhasin, Swati https://orcid.org/0000-0001-8661-1459
Bhasin, Manoj
-
Funding
Funding for this research was provided by:
The study is supported through funding from the Children’s Oncology Group—Alexis and Jerry Bednyak Foundation Award for Research in High-Risk Leukemia
- License Information
-
More Information
Article History
Received: 25 November 2024
Revised: 15 July 2025
Accepted: 18 August 2025
First Online: 10 September 2025
Change Date: 19 September 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41375-025-02773-6
Competing interests
: The authors declare no competing interests.
: All methods in this study were performed in accordance with the relevant guidelines and regulations. Single-cell RNA sequencing data sets were procured from publicly available repositories. Informed consent and institutional review board approval were obtained in the respective studies [–]. Ex vivo drug sensitivity studies were performed under informed consent and institutional review board approval (Emory University IRB #00034535).
